Biotech pharmaceuticals and biotherapy: an overview

Area of Science:

• Biotechnology
• Pharmaceutical Sciences
• Molecular Biology

Background:

• The history of pharmaceutical biotechnology traces back to penicillin's discovery and large-scale production.
• Key breakthroughs in the 1970s, including genetic material transplantation and hybridoma technology, formed the modern biotech industry.

Purpose of the Study:

• To review the products of pharmaceutical biotechnology, focusing on recombinant pharmaceuticals.
• To compare the safety and effectiveness of biotech pharmaceuticals with conventionally produced ones.
• To discuss the regulatory landscape for biotech pharmaceuticals.

Main Methods:

• The review synthesizes information on the development and application of pharmaceutical biotechnology.
• It examines gene cloning and recombinant DNA technology as core methods.
• Focus is placed on the outcomes and characteristics of biotech pharmaceutical products.

Main Results:

• Modern pharmaceutical biotechnology utilizes gene cloning and recombinant DNA technology to produce medically useful substances.
• Recombinant DNA technology allows for the modification of organisms to yield scarce human proteins.
• The review details various types of biotech pharmaceuticals and their comparative safety and effectiveness.

Conclusions:

• Pharmaceutical biotechnology has advanced significantly, offering novel therapeutic products.
• Recombinant pharmaceuticals represent a major class of biotech products with distinct production methods.
• Understanding the safety, efficacy, and regulation of these products is crucial.